Mitochondrial CypD Acetylation Promotes Endothelial Dysfunction and Hypertension.
Anna DikalovaDaniel J FehrenbachVladimir MayorovAlexander PanovMingfang AoLouise LantierVenkataraman AmarnathMarcos G LopezFrederic T BillingsMichael N SackSergey I DikalovPublished in: Circulation research (2024)
These data support the pathogenic role of CypD acetylation in endothelial dysfunction and hypertension. We suggest that targeting cytotoxic mitochondrial isolevuglandins and GCN5L1 reduces CypD acetylation, which may be beneficial in cardiovascular disease.